John A. Levi
Impact in
- Oncology top 2%
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
- Cancer Diagnosis and Treatment
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 26
- Cancer Treatment and Pharmacology 8
- Neutropenia and Cancer Infections 6
- Cancer Diagnosis and Treatment 5
-
- Lymphoma Diagnosis and Treatment 10
- Co-authors
- Peter H. Wiernik (11 shared papers)Walter O. Spitzer (1 shared paper)Barry R. Catchlove (1 shared paper)Annette Jane Dobson (1 shared paper)Jane P Hall (1 shared paper)Renaldo N. Battista (1 shared paper)Robert L. Woods (13 shared papers)David N. Dalley (13 shared papers)
- Journals
- The Medical Journal of Australia (12 papers)Cancer (11 papers)Journal of Clinical Oncology (4 papers)British Journal of Cancer (3 papers)Investigational New Drugs (3 papers)
- Partner nations
- AustraliaUnited StatesBelgium
In The Last Decade
John A. Levi
86 papers receiving 3.8k citations
John A. Levi's Hit Papers
Peers
Comparison fields: 5 of 119
- Oncology 1.1k
- Pathology and Forensic Medicine 476
- Dermatology 173
- Pulmonary and Respiratory Medicine 631
- Genetics 118
Countries citing papers authored by John A. Levi
This map shows the geographic impact of John A. Levi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Levi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Levi more than expected).
Fields of papers citing papers by John A. Levi
This network shows the impact of papers produced by John A. Levi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Levi. The network helps show where John A. Levi may publish in the future.
Co-authors
The 25 scholars most cited alongside John A. Levi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Measuring the quality of life of cancer patients Hit paper breakdown → | 1981 | 1317 |
| 2 | 1987 | 326 | |
| 3 | 1999 | 183 | |
| 4 | 1997 | 168 | |
| 5 | 1980 | 137 | |
| 6 | 1990 | 132 | |
| 7 | 1980 | 119 | |
| 8 | 2001 | 107 | |
| 9 | 1975 | 92 | |
| 10 | 2000 | 91 | |
| 11 | 1997 | 72 | |
| 12 | 1999 | 69 | |
| 13 | 1981 | 68 | |
| 14 | 1973 | 63 | |
| 15 | 1977 | 63 | |
| 16 | 1986 | 63 | |
| 17 | 1974 | 60 | |
| 18 | 2010 | 57 | |
| 19 | 1977 | 50 | |
| 20 | 1979 | 50 |
About John A. Levi
John A. Levi is a scholar working on Oncology, Pathology and Forensic Medicine, Hematology, Cancer Research and Reproductive Medicine, having authored 87 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (10 papers), Testicular diseases and treatments (8 papers), Cancer Treatment and Pharmacology (8 papers), Breast Cancer Treatment Studies (7 papers), Acute Myeloid Leukemia Research (6 papers), Neutropenia and Cancer Infections (6 papers), Cancer Diagnosis and Treatment (5 papers) and Palliative Care and End-of-Life Issues (5 papers). The work is most often cited by research in Oncology (1.1k citations), Pathology and Forensic Medicine (476 citations), Dermatology (173 citations), Pulmonary and Respiratory Medicine (631 citations) and Genetics (118 citations). John A. Levi has collaborated with scholars based in Australia, United States and Belgium. Frequent co-authors include Peter H. Wiernik, Walter O. Spitzer, Barry R. Catchlove, Annette Jane Dobson, Jane P Hall, Renaldo N. Battista, Robert L. Woods, David N. Dalley, Nick Pavlakis and R. S. Aroney. Their work appears in journals such as The Medical Journal of Australia, Cancer, Journal of Clinical Oncology, British Journal of Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.